Starling Oncology Warrant
STLNW
29 hedge funds and large institutions have $5.4M invested in Starling Oncology Warrant in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
58% more capital invested
Capital invested by funds: $3.42M → $5.4M (+$1.98M)
16% more funds holding
Funds holding: 25 → 29 (+4)
6.76% more ownership
Funds ownership: 5.57% → 12.32% (+6.8%)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$2.32M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$690K |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$482K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$116K |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$113K |
| 2 |
KC
Kepos Capital
New York
|
-$112K |
| 3 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$24K |
| 4 |
JG
Jefferies Group
New York
|
-$19.4K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$5.09K |
STLNW Hedge Fund Activity: Q1 2021 in Review
29 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Warrant (STLNW) for Q1 2021, worth a combined $5.4M — up 58% from $3.42M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new STLNW positions and 3 closed out — a net gain of 4 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $2.32M. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $113K sold.
- 29 institutional investors held Starling Oncology Warrant (STLNW) as of Q1 2021, up from 25 in Q4 2020.
- Funds reported $5.4M of Starling Oncology Warrant stock for Q1 2021, up 58% quarter-over-quarter.
- 7 funds opened new Starling Oncology Warrant positions in Q1 2021 and 3 closed out, a net change of +4 holders.
- The largest Starling Oncology Warrant buyer in Q1 2021 was Deerfield Management, an estimated $2.32M added.
- The largest Starling Oncology Warrant seller in Q1 2021 was Fir Tree Capital Management, an estimated $113K sold.
Based on aggregated 13F filings for Q1 2021.